课题基金 / 基金详情

The endothelial TM-PC system regulates tubular senescence and regeneration via p21 in diabetic nephropathy

The endothelial TM-PC system regulates tubular senescence and regeneration via p21 in diabetic nephropathy
糖尿病肾病中内皮TM-PC系统通过p21调节肾小管衰老和再生
批准号:
317304630
负责人:
Professor Dr. Berend Isermann
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2021-12-31

项目摘要

项目成果

Professor Dr. Berend Isermann的其他基金

相似基金

相关文献

中文摘要
翻译
在糖尿病肾病中,内皮TM-PC系统通过p21调节肾小管的衰老和再生糖尿病肾病(DNP)是工业化国家终末期肾脏疾病的主要原因。肾小管间质纤维化比肾小球硬化更能预测肾功能的下降。然而,肾小管损伤的病理机制仍然很大程度上是未知的,阻碍了新的治疗方法的发展。后者在一定程度上反映了缺乏合适的动物模型。我们建立了一个糖尿病小鼠模型,糖尿病小鼠体内内皮细胞依赖的丝氨酸蛋白酶激活蛋白C(APC,一种细胞保护和抗凝蛋白C)水平降低,如果糖尿病,就会出现明显的肾小管间质纤维化,使我们能够研究糖尿病肾小管间质纤维化的调控机制。初步工作证实,这些小鼠的p21表达增加,肾小管衰老加快。体外研究表明,APC调节p21的表达和肾小管的衰老。小管p21的表达受表观遗传调控,因此可能有助于代谢记忆。重要的是,恢复APC依赖的信号可以逆转这些变化,表明这种病理机制在治疗上是可以修正的。根据这些结果,我们推测内皮功能障碍和缺失APC导致持续的p21表达和肾小管衰老,从而损害DNP的肾小管再生能力。我们假设,这将加重慢性肾小管损伤,但也会损害既有DNP(急性对慢性肾损伤)的急性肾损伤后的肾小管修复。APC依赖的肾小管衰老和肾小管再生的调节将提供一个连接内皮功能障碍和肾小管损伤的新框架,并将为DNP的慢性肾损伤和急性肾损伤后肾小管再生受损提供统一的机制。为了评估所提出的机制,我们打算解决以下目标:目的1:阐明APC和p21在控制dNP肾小管细胞增殖和修复中的机制相互作用。目的2:明确高血糖诱导和持续的肾小管p21表达与急性肾损伤后预后损害的机制相关性。目的3:确定APC限制p21表达的机制。
英文摘要
The endothelial TM-PC system regulates tubular senescence and regeneration via p21 in diabetic nephropathyDiabetic nephropathy (dNP) is the leading cause of end stage renal disease in industrialized countries. Tubulointerstitial fibrosis predicts the decline of renal function better then glomerulosclerosis. The pathomechanisms of tubular injury remain, however, largely unknown, hampering the development of new therapeutic approaches. The latter reflects in part the lack of suitable animal models. We developed a mouse model, diabetic mice with reduced levels of the endothelial cell dependent serine protease activated protein C (aPC, a cytoprotective and anticoagulant protease), which develop marked tubulointerstitial fibrosis if diabetic, enabling us to study mechanisms regulating diabetic tubulointerstitial fibrosis. Preliminary work identified increased expression of p21 and increased tubular senescence in these mice. In vitro studies demonstrate that aPC regulates p21 expression and tubular senescence. Tubular p21 expression is epigenetic regulated, thus potentially contributing to the metabolic memory. Importantly, restoring aPC-dependent signalling can reverse these changes, demonstrating that this pathomechanisms is therapeutically amendable. Based on these results we hypothesize that endothelial dysfunction and loss aPC causes sustained p21 expression and tubular senescence, thus impairing the re-generative tubular capacity in dNP. We hypothesize that this will aggravate chronic tubular injury, but also impair tubular repair after an acute renal injury in pre-existing dNP (acute on chronic kidney injury). The aPC-dependent regulation of tubular senescence and hence tubular regeneration would provide a new framework linking endothelial dysfunction and tubular injury and would provide a unifying mechanism underlying the chronic tubular injury as well as the impaired tubular regeneration after acute kidney injury in dNP. To evaluate the proposed mechanism we intend to address the following aims: Aim 1: Delineate the mechanistic interaction of aPC and p21 in controlling tubular cell proliferation and repair in dNP.Aim 2: Define the mechanistic relevance of hyperglycaemia induced and sustained tubular p21 expression for impaired outcome following acute renal injury.Aim 3: Identify the mechanism through which aPC restricts p21 expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protease dependent signalling at the glomerular filtration barrier
Systemdiagnostik entzündlicher Prozesse
Characterization of mechanisms through which coagulation proteases differentially regulate hyperglycemia and hyperlipidemia induced accelerated atherosclerosis.
Defining the mechanisms through which the transcription factor Nfe2 regulates trophoblast differentiation
国内基金
海外基金
靶向TM4SF1促进肝细胞癌衰老并增敏免疫治疗的机制研究
  • 批准号:
    JCZRYB202500422
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
TM@NCNTs/CF阴极的光电催化体系协同还原铀和降解有机污染物的研究
  • 批准号:
    2025JJ60275
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    王嘉琛
  • 依托单位:
TM6SF2 E167K、PNPLA3 I148M基因多态性与非酒精性脂肪肝病的关联分析
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    于丽侠
  • 依托单位:
基于异原子掺杂调控TM LDHs超结构晶面取向及电催化性能
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    黄桂芳
  • 依托单位: